Grant: Chair: GlaxoSmithKline Partnered
Memorial University of Newfoundland
$71,875.00
Epigenetics and Epigenomics of Head and Neck Cancer
EF 2017-18
Résumé
Cancers of the head and neck are solid tumors arising in the oral cavity, oropharynx, hypopharynx, larynx, and nasopharynx. Unfortunately, there are few biomarkers that can be reliably used either in early detection of this disease, or as indicators of patient outcome. This study will utilize genome-wide measurements of tumor DNA to better classify sub-types of this disease in order to improve patient treatment and outcome.
Programme
Chair: GlaxoSmithKline Partnered
Bénéficiaire
Emplacement
Newfoundland and Labrador, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
366104
Name
Belbin Thomas J
Region
Newfoundland and Labrador
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
GlaxoSmithKline (Mississauga, Ontario)
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
CIHR/GSK Partnered Chair Program
Projecttitle
Epigenetics and Epigenomics of Head and Neck Cancer
Programtype2
Salary Programs
Orgnameinp2
Memorial University of Newfoundland
Cihramount2
$71,875
Cihrequipment2
$0
Programname2
Chair: GlaxoSmithKline Partnered
Keyworddelim
Cancer Gene Signature; Dna Methylation; Epigenetic Modulation; Gene Silencing; Head And Neck Cancer; Molecular Classification; Pathogenesis; Prognostic Modelling; Tumor Metastasis; Znf Transcription Factors
Abstract
Cancers of the head and neck are solid tumors arising in the oral cavity, oropharynx, hypopharynx, larynx, and nasopharynx. Unfortunately, there are few biomarkers that can be reliably used either in early detection of this disease, or as indicators of patient outcome. This study will utilize genome-wide measurements of tumor DNA to better classify sub-types of this disease in order to improve patient treatment and outcome.
Competitiondate
201704
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Belbin, Thomas J
Approvedterm
5 ans 0 mois
Cihrcontribution2
Major Initiatives #2~ $71,875~ $0~
